Angelini is a multi-business, multinational industrial group, rebranded as Angelini Industries, with its primary operations in Health, Consumer Goods, and Industrial Technology. Founded in Italy in 1919 by Francesco Angelini, it remains a privately held, family-owned company headquartered in Rome.

Overview of Operations

Angelini Industries operates directly in 21 countries, employing approximately 5,800 people and generating over €2.1 billion in revenues in 2023. The company is guided by a long-term vision that emphasizes sustainability, research, and development.

Key divisions within the group include:

Angelini Pharma:
The primary health sector division, focused on the research, development, and marketing of pharmaceutical solutions. Its main therapeutic areas include Brain Health (mental health and epilepsy), Specialty and Primary Care (pain management, fever, anti-infectives), and Consumer Healthcare. Notable products include Trazodone (antidepressant), Benzydamine (anti-inflammatory), Tachipirina (paracetamol), and Ontozry (epilepsy treatment).

Angelini Technologies:
This division is dedicated to industrial technology, primarily through its company Fameccanica. It designs and develops advanced automation and robotics solutions for the industrial production of consumer goods, with a focus on sustainable packaging and logistics.

Consumer Goods:
Angelini operates in this sector through partnerships and wholly-owned companies, including Fater (a 50/50 joint venture with Procter & Gamble for personal and home care products like Amuchina disinfectants) and Angelini Wines & Estates, which produces premium Italian wines.

Angelini Ventures:
The group’s venture capital arm, launched with a €300 million commitment to invest in early-stage biotech and digital health companies that aim to transform healthcare.

Angelini Industries is recognized for its commitment to R&D and has been consistently named a “Top Employer” in Europe for its employee development and workplace practices.